Gaithersburg-based drug maker MedImmune loses one patent suit in
Daily Record, The (Baltimore), Jan 11, 2007 by Daily Record Staff
Gaithersburg-based drug maker MedImmune Inc. said a U.S. court rejected a motion by Indian drugmaker Sun Pharmaceutical Industries Ltd. to drop an infringement suit on one patent, but ruled another was not infringed by Sun. The U.S. District Court for the District of Maryland denied a summary judgment requested by Sun for one patent protecting MedImmune's sole cancer product, called Ethyol.
However, the court ruled that another patent protecting Ethyol was not infringed by Sun.
Copyright 2007 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
Most Popular Business Publications
Content provided in partnership with
